-
August 20, 2021 Psychedelic Business Spotlight: August 20, 2021This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked,...
-
August 17, 2021 Why PsyBio Is Using Biosynthetic Psilocybin, Not Mushrooms, to Build Better Therapeutics"A mushroom is not a pharmaceutical product," CEO Evan Levine stresses, and explains why his...
-
August 17, 2021 MindMed’s Q2 Earnings Call: What does the future hold for MNMD/ MMED?Check out atai Life Sciences' earnings call: https://www.youtube.com/watch?v=lkE3EmU0o_w What's up psychedelic stocks investors?!? Today marked...
-
August 16, 2021 Beckley Psytech Raises $80 Million to Fund Psychedelic Research PipelineThe company will use proceeds of the fundraising round to complete its ongoing Phase 1B...
-
August 16, 2021 atai Life Sciences Q2 Conference Call and Questions & Answer Period: BIG NEWS for Psychedelic StocksWhat's up psychedelic stocks investors?!? Today marked atai Life Science's (Nasdaq: atai) first-ever conference call,...
-
August 15, 2021 MindMed Financial Results & Business Update Q2 2021 ( Where Does MNMD/MMED Go From Here?)MindMed's Financial Results & Business Update for Q2 2021 are out! In this episode, we'll...
-
August 13, 2021 How Ayahuasca and Volcanic Disaster Pulled Microdosing Mentor Laura Dawn Out of the ‘Psychedelic Closet’The Psychedelic Spotlight podcast guest also addresses criticism that she is a white woman working...
-
August 13, 2021 Psychedelic Business Spotlight: August 13, 2021This week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke;...
-
August 13, 2021 Mydecine Joins the BIG LEAGUES! MYCO + Johns Hopkins to treat smoking addiction with MAGIC MUSHROOMSMydecine (OTC: MYCOF, NEO: MYCO) is an aspiring psychedelics medicine company that aims to use...
-
August 12, 2021 Nova Mentis Reaches Milestone Developing Psilocybin to Treat AutismNova Mentis says that psilocybin could be a novel, first-in-class treatment for a brain disorder...
